...
首页> 外文期刊>International immunopharmacology >Comparison between the efficacy of intralesional rituximab versus intralesional triamcinolone in the treatment refractory Pemphigus Vulgaris lesions: A randomized clinical trial
【24h】

Comparison between the efficacy of intralesional rituximab versus intralesional triamcinolone in the treatment refractory Pemphigus Vulgaris lesions: A randomized clinical trial

机译:腔内蓖麻毒素与腔内枝氨酮在治疗难治性Pemphigus的疗效之间的比较:随机临床试验

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Pemphigus Vulgaris (PV) is a vesiculobullous autoimmune disorder characterized by production of autoantibody against cellular adhesion molecules. The treatment of PV is based on the use of systemic corticosteroid along with immunosuppressive therapy, but sometimes there are limited resistant lesions not responding to conventional systemic therapy. This double-blind, randomized clinical trial was designed to evaluate the efficacy of intralesional rituximab versus triamcinolone in treatment of the refractory scalp and mucosal pemphigus lesions.
机译:背景:Pemphigus Vulgaris(PV)是一种植物的自身免疫疾病,其特征是通过对细胞粘附分子产生自身抗体的影响。 PV的治疗是基于使用全身皮质类固醇以及免疫抑制治疗的使用,但有时耐受有限的病变没有响应常规的全身疗法。 这种双盲随机临床试验旨在评估腔内Rituximab与Triamcinolone治疗难治性头皮和粘膜Pemphigus病变的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号